Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Urinary Bladder Neoplasms × Population Groups × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 7 Neoplasms 3 Hemangioma, Capillary 2 Anxiety Disorders 2 Weight Loss 1 Vomiting 1 Urinary Incontinence, Stress 1 Urinary Incontinence 1 Urinary Bladder Neoplasms 1 Shoulder Pain 1 Respiratory Aspiration 1 Psychomotor Agitation 1 Prostatic Neoplasms 1 Premature Birth 1 Polycystic Ovary Syndrome 1 Pediatric Obesity 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Ovarian Cysts 1 Obesity 1 Neuromuscular Diseases 1 Nasopharyngeal Carcinoma 1 Myofibroma 1 Myelodysplastic Syndromes 1 Myasthenia Gravis 1 Multiple Myeloma 1 Menstruation Disturbances 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Liver Cirrhosis 1

Interventions

Gemcitabine 74 Cisplatin 57 Cystectomy 36 pembrolizumab 30 Docetaxel 24 durvalumab 21 Nivolumab 20 Paclitaxel 17 Radiotherapy 16 Magnetic Resonance Spectroscopy 15 Mitomycin 14 Carboplatin 13 Doxorubicin 12 Cystoscopy 12 atezolizumab 11 Standard of Care 11 BCG Vaccine 11 avelumab 10 tremelimumab 9 Surveys and Questionnaires 9 Sunitinib 9 Specimen Handling 8 Ipilimumab 8 Filgrastim 8 Blood Specimen Collection 8 Transurethral Resection of Bladder 7 Neoadjuvant Therapy 7 Methotrexate 7 Methods 7 Early Intervention, Educational 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02676180 2023-12-08

DETECT I

University College, London

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡